Skip to main content
×
×
Home

Clinician hesitation prior to clozapine initiation: is it justifiable?

  • Maxine X. Patel (a1)
Summary

Clozapine has been endorsed by national clinical guidelines for 10 years and yet underutilisation and delay to initiation remain rife. Although there will be good clinical reasons for clozapine not being initiated for some patients, it is hypothesised here that for others, clinicians' attitudes and preferences are the most likely predictive factors.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Clinician hesitation prior to clozapine initiation: is it justifiable?
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Clinician hesitation prior to clozapine initiation: is it justifiable?
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Clinician hesitation prior to clozapine initiation: is it justifiable?
      Available formats
      ×
Copyright
References
Hide All
1 Kane, J, Honigfeld, G, Singer, J, Meltzer, H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789–96.
2 Howes, OD, Vergunst, F, Gee, S, McGuire, P, Kapur, S, Taylor, D. Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation. Br J Psychiatry 2012; 201: 481–5.
3 National Institute for Health and Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update) (Clinical Guideline CG82). NICE, 2009.
4 Taylor, DM, Young, C, Paton, C. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review. J Clin Psychiatry 2003; 64: 30–4.
5 Nielson, J, Dahm, M, Lublin, H, Taylor, D. Psychiatrists' attitude towards and knowledge of clozapine treatment. J Psychopharmacol 2010; 24: 965–71.
6 Farooq, S, Taylor, M. Clozapine: dangerous orphan or neglected friend? Br J Psychiatry 2011; 198: 247–9.
7 Taylor, DM, Douglas-Hall, P, Olofinjana, B, Whiskey, E, Thomas, A. Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection. Br J Psychiatry 2009; 194: 165–7.
8 Tiihonen, J, Lonnqvist, J, Wahlbeck, K, Klaukka, T, Niskanen, L, Tanskanen, A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009; 374: 620–7.
9 Whiskey, E, Olofinjana, O, Taylor, D. The importance of the recognition of benign ethnic neutropenia in black patients during treatment with clozapine: case reports and database study. J Psychopharmacol 2011; 25: 842–5.
10 Pai, NB, Vella, SC. Reason for clozapine cessation. Acta Psychiatr Scand 2011; 124: 3944.
11 Taylor, D, Paton, C, Kapur, S. Maudsley Prescribing Guidelines, 11th Edition. Wiley Blackwell, 2012.
12 Leucht, S, Corves, C, Arbter, D, Engel, RR, Li, C, Davis, JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a metaanalysis. Lancet 2009; 373: 3141.
13 Girgis, RR, Phillips, MR, Li, X, Li, K, Jiang, H, Wu, C, et al. Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial. Br J Psychiatry 2011; 199: 281–8.
14 Lewis, SW, Barnes, TR, Davies, L, Murray, RM, Dunn, G, Hayhurst, KP, et al. Randomized controlled trial of effect of prescription for clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull 2006; 32: 715–23.
15 McEvoy, JP, Liebermann, JA, Stroup, TS, Davis, SM, Meltzer, HY, Rosenheck, RA, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry 2006; 163: 600–10.
16 Couchman, L, Morgan, PE, Spencer, EP, Flanagan, RJ. Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service. Ther Drug Monit 2010; 32: 438–47.
17 Couchman, L, Bowskill, SV, Handley, S, Patel, MX, Flanagan, RJ. Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged < 18 years: data from a therapeutic drug monitoring service, 1994-2010. Early Interv Psychiatry 2012; 2 Jul, doi: 10.1111/j.1751-7893.2012.00374.X (ePub ahead of print).
18 Tiihonen, J, Haukka, J, Taylor, M, Haddad, PM, Patel, MX, Korhonen, P. A nationwide cohort study of oral and depot antipsychotics after first hopitalization for schizophrenia. Am J Psychiatry 2011; 168: 603–9.
19 Downs, J, Zinkler, M. Clozapine: national review of postcode prescribing. Psychiatr Bull 2007; 31: 384–7.
20 Patel, MX, David, AS. Why aren't depot antipsychotics prescribed more often and what can be done about it? Adv Psychiatr Treat 2005; 11: 203–11.
21 Best-Shaw, L, Nagar, J, David, AS, Rose, D, Patel, MX. Psychiatrists' perspectives regarding antipsychotics: Dose choice and plasma level therapeutic drug monitoring. J Psychopharmacol 2012; 26 (suppl 8): A39.
22 Royal College of Psychiatrists. National Audit of Schizophrenia (NAS). Royal College of Psychiatrists, 2011. (http://www.rcpsych.ac.uk/quality/nationalclinicalaudits/schizophrenia/nationalschizophreniaaudit.aspx).
23 Harrison, PJ, Baldwin, DS, Barnes, TRE, Burns, T, Ebmeier, KP, Ferrier, IN, et al. No psychiatry without psychopharmacology. Br J Psychiatry 2011; 199: 263–5.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 17 *
Loading metrics...

Abstract views

Total abstract views: 40 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 26th April 2018. This data will be updated every 24 hours.

Clinician hesitation prior to clozapine initiation: is it justifiable?

  • Maxine X. Patel (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *